Live Updates:

On | Off

  • ENTEROMEDICS INC Financial Overview

  • Income Statement: ETRM

      2009 2008 Change ( 2008 - 2009  )
    Net Sales/Revenues 0.00 0.00 0.00 N/A%
    Gross Profit 0.00 -513,060.00 513,060.00 ∞ T%
    Net Income Before Extra Items/Preferred Div -31.93 M -37.87 M 5.94 M -18.62%
    Operating Income -24.21 M -36.27 M 12.06 M -49.80%
  • Cash Flow: ETRM

      2009 2008 Change ( 2008 - 2009  )
    Net Cash Flow - Financing 3.16 M 46.32 M -43.16 M -1,365.55%
    Net Cash Flow - Investing -2.83 M -8.25 M 5.41 M -191.26%
    Net Cash Flow/Operating Activities -33.67 M -23.37 M -10.30 M 30.59%
  • Balance Sheet: ETRM

      2009 2008 Change ( 2008 - 2009  )
    Total Assets 16.21 M 28.28 M -12.06 M -74.41%
    Total Liabilities 10.63 M 16.87 M -6.24 M -58.69%
    Shareholders Equity 5.58 M 11.40 M -5.82 M -104.35%
  • Key Ratios / Statistics: ETRM

    • Valuation

      Price/Earnings (TTM) -0.65
      Price/Sales (TTM)
      Price/Book (MRQ) 43.99
      Price/Cash Flow (TTM) -1.03
    • Profitability

      Gross Margin
      Operating Margin
      Profit Margin
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 4.48
      Current Ratio (MRQ) 444.18
      Long Term Debt-to-Equity (MRQ) 139.06
    • Management Effectiveness

      Return on Equity (TTM) -133.52
      Return on Assets (TTM) -116.27
      Return on Investments (TTM) -88.71